BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9804	Companies
196641	Keywords
127659	Articles
104549	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 08/15/2024 at 09:10, 1 year 5 months ago

BioNxt signe une lettre d'intention avec Gen-Plus GmbH & Co KG pour d'éventuelles collaborations commerciales

Partenariat Cladribine Développement Pharmaceutique Solutions BioNxt Gen-Plus GmbH
PRESS RELEASE

published on 08/15/2024 at 09:05, 1 year 5 months ago

BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations
BioNxt Solutions Inc. signs non-binding LOI with Gen-Plus GmbH & Co KG, part of Conscio Group, for potential cooperation in pharmaceutical products and clinical trials. Details to follow

Clinical Trials Pharmaceutical BioNxt Solutions Inc. LOI Gen-Plus GmbH
BRIEF

published on 07/17/2024 at 09:10, 1 year 6 months ago

BioNxt Signs Statement of Work with International CRDMO for Cladribine ODF Development

Multiple Sclerosis Pharmaceutical Development BioNxt Solutions Cladribine ODF CRDMO
BRIEF

published on 07/17/2024 at 09:10, 1 year 6 months ago

BioNxt signe une déclaration de travail avec le CRDMO international pour le développement de la cladribine ODF

Sclérose En Plaques Développement Pharmaceutique Solutions BioNxt Cladribine ODF CRDMO
PRESS RELEASE

published on 07/17/2024 at 09:05, 1 year 6 months ago

BioNxt Signs Statement of Work with International Contract Research, Development, And Manufacturing Organization for Cladribine ODF Development
BioNxt Solutions Inc. signs agreement with German CRDMO for Cladribine oral dissolvable film development program targeting the lucrative multiple sclerosis market

BioNxt Solutions Inc. Cladribine CRDMO Oral Dissolvable Film MS Market
BRIEF

published on 07/09/2024 at 09:10, 1 year 6 months ago

BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization

Drug Development Pharmaceutical Market Master Services Agreement BioNxt Solutions Cladribine ODF
BRIEF

published on 07/09/2024 at 09:10, 1 year 6 months ago

BioNxt signe un accord-cadre de services avec une organisation internationale de recherche, de développement et de fabrication sous contrat

Marché Pharmaceutique Développement De Médicaments Solutions BioNxt Cladribine ODF Contrat-cadre De Services
PRESS RELEASE

published on 07/09/2024 at 09:05, 1 year 6 months ago

BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization
BioNxt Solutions Inc. signs master services agreement with German-based CRDMO for product development of oral dissolvable drug formulations

BioNxt Solutions Inc. Product Development Master Services Agreement CRDMO Oral Dissolvable Drug Formulations
BRIEF

published on 06/20/2024 at 01:05, 1 year 7 months ago

BioNxt Solutions Closes Second Tranche of Private Placement

Private Placement Common Shares Warrants Research Funding BioNxt Solutions
BRIEF

published on 06/20/2024 at 01:05, 1 year 7 months ago

BioNxt Solutions clôture la deuxième tranche de placement privé

Placement Privé Actions Ordinaires Bons De Souscription Financement De La Recherche Solutions BioNxt

Accesswire

Published on 02/05/2026 at 00:00, 1 hour 26 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 3 hours 1 minute ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 7 hours 26 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 9 hours 11 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 9 hours 41 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 20:54, 4 hours 32 minutes ago

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 4 hours 50 minutes ago

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 5 hours 26 minutes ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 6 hours 31 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 6 hours 46 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology

Les Echos

Published on 02/04/2026 at 18:04, 7 hours 22 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 7 hours 22 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 7 hours 41 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 7 hours 41 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 7 hours 41 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE